Clik here to view.
CardioKinetix在中国启动治疗心力衰竭的同类器械中首款Parachute器械的研究
加州门洛帕克 (美国商业资讯) — CardioKinetix Inc.是一家心力衰竭导管治疗领域的先驱性医疗器械公司。该公司今天宣布，Parachute研究在中国入组首例患者，该研究为多中心试验，旨在评估微创Parachute®心室隔离器械用于治疗心力衰竭。 最初10例患者在北京大学和阜外医院，以及上海第十人民医院经Parachute器械进行了治疗。...
View ArticleClik here to view.
ChinaBio® Partnering Forum 2015 to be held in Shanghai, China April 22–23, 2015
CARLSBAD, Calif. & SHANGHAI The 2015 edition of ChinaBio® Partnering Forum, China’s premier life science partnering event, will be held April 22–23 in Shanghai. Shanghai is the largest city...
View ArticleClik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Shows Double Digit Increases Over 2013
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its third quarter Global Life Sciences Hiring Index. The Index posts its highest score in nearly five years, even with the European...
View ArticleClik here to view.
Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study....
View ArticleClik here to view.
EOS imaging Obtains Marketing Approval in South Korea
PARIS EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopaedic medical imaging, today announced that the Company has received approval from the Korean Food and Drug...
View ArticleClik here to view.
Cerus Announces Agreement With Kawasumi Laboratories for the Development of...
CONCORD, Calif. Cerus Corporation (NASDAQ: CERS) announced today that it has entered into a partnership agreement with Kawasumi Laboratories to develop an INTERCEPT platelet kit designed for use in...
View ArticleClik here to view.
Vantage Health Forms Strategic Partnership with Theranostics Laboratory
REDWOOD CITY, Calif. Vantage Health Inc., (OTCQB:VNTH) (“Vantage Health”) or (the “Company”) today announced that it has entered into a strategic partnership with Theranostics Laboratory, a...
View ArticleClik here to view.
Spinal Stenosis : Non-Surgical Treatment by Best Center in Thailand at...
BANGKOK Phyathai Nawamin International Hospital recognizes the importance of the disease, spinal stenosis, which has created pain and agony for patients. It also affects the daily life of the...
View ArticleClik here to view.
Hoya Announces Second Quarter Financial Results
TOKYO Hoya Corporation (TOKYO: 7741) today announced financial results for the second quarter ended September 30, 2014. During the quarter, revenues totaled 121,242 million yen, increasing by 18.6%...
View ArticleClik here to view.
Akebiaが慢性腎臓病に関連した貧血を伴う非透析患者を対象にAKB-6548を検討した第2b相試験で、優れて良好な結果が得られたと発表
米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 低酸素誘導因子（HIF）の生物学を通じて腎臓病患者に革新的治療薬を提供することに傾注するバイオ製薬企業のAkebia Therapeutics,...
View ArticleClik here to view.
ピーエスシー、社名を「ファインデックス」に変更
愛媛県松山市 （ビジネスワイヤ） — 株式会社ピーエスシー（JASDAQ：3649 本社：愛媛県松山市三番町4-9-6 社長：相原輝夫）は、事業強化の為、「ファインデックス（FINDEX）」に社名を変更することをお知らせいたします。 新社名 株式会社ファインデックス（英名：FINDEX Inc.） 変更日 2014年11月1日 会社情報...
View ArticleClik here to view.
ImpediMed Announced Medicare Payment for New L-Dex® Category I Code
BRISBANE, Australia & SAN DIEGO ImpediMed (ASX:IPD) is pleased to announce today the Centers for Medicare and Medicaid Services (CMS) has published the valuation for CPT® Category I Code 93702...
View ArticleClik here to view.
Ascom Establishes Distribution in Mexico
RESEARCH TRIANGLE PARK, N.C. Ascom (US), Inc., a leading provider of mission-critical healthcare communication solutions, is pleased to announce its establishment of distribution into Mexico. A key...
View ArticleClik here to view.
Theorem Clinical Research Expands Leadership and Prepares for Growth with...
KING OF PRUSSIA, Pa. Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, has named Kathryn Bohannon as vice president of biopharmaceutical development...
View ArticleClik here to view.
Study Shows Positive Clinical and Potential Economic Outcomes with V.A.C....
SAN ANTONIO Acelity is pleased to announce the publication of a peer-reviewed study that suggests V.A.C. VeraFlo™ Therapy (NPWTi-d) may be more cost effective than standard V.A.C.® Therapy (NPWT)....
View ArticleClik here to view.
Avedro Granted Korean Approval for its KXL® Cross-Linking System for Lasik Xtra®
WALTHAM, Mass. Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today that it has been granted approval from the South Korean Ministry of Food and Drug...
View ArticleClik here to view.
pSivida Corp. Reports First Quarter FY 2015 Results
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced financial results for its...
View ArticleClik here to view.
GE Healthcare and Takeda Join Forces to Develop Therapeutic Drugs to Target...
CHALFONT ST. GILES, England & OSAKA, Japan GE Healthcare and Takeda Pharmaceutical Company announced that they have entered into an alliance agreement for research and development in the field...
View ArticleClik here to view.
Nipro Medical Corporation Introduces the First Dialyzer in the US without BPA...
BRIDGEWATER, N.J. Nipro Medical Corporation, a subsidiary for North & South America Sales and Marketing of Nipro Corporation in Japan, a world leader in dialyzer design and manufacturing,...
View Article